Our Promise
Making diagnostics accessible
Our sensitive methodology, combining padlock probes and rolling circle amplification (RCA) with microfluidics, achieves the robustness and specificity of RT-PCR in a low cost rapid test.
We offer rapid, sensitive and cost-effective diagnostics
-
Accessible
Testing where and when this is needed. The first line of defense against infectious disease. Our tests do not require any instrumentation. Get an accurate yes or no in the palm of your hand about ongoing infection.
-
Fast
When time to answer is of the essence. From sample to results in just 15 minutes!
-
Low cost
Our instrument-free platform is built like a lateral flow test with the benefits of low cost and ease of use but offering the high sensitivity and specificity of a clinical laboratory test.
-
Scalable
The padlock probe methodology inside our tests lends itself for multiplex analyses that are easy to adapt to new target variants. Production of the platform is easy to scale up.
Our Team
Liza Löf, PhD.
CEO
Liza holds a PhD in molecular medicine from 2016. She has a strong academic record and profound knowledge of the technologies that are the foundation of the products. Previous experience from the medical device industry in R&D, process development and project management.
Sofia Larsson, MSc.
Research Engineer
Sofia holds a Master in molecular biotechnology engineering from Uppsala University with focus on production. Sofia has experience from working in life science industry and regulatory. Sofia also has many years of experience from working in several non-profit boards.
Despoina Kermpatsou, PhD. Scientist
Despoina is a molecular biologist with significant experience in DNA-based method development and oligonucleotide design in innovative molecular assays. Despoina has a Master of Science in Clinical Pharmacology from Democritus University of Thrace, Greece, and a PhD in Pharmaceutical Cell Biology from Uppsala University, Sweden.
Ehsan Manouchehri, PhD. Scientist
Ehsan has a strong academic background in Microbiology and Immunology, complemented by a Ph.D. in Molecular Medicine from Uppsala University. Great expertise in molecular assay development, oligo design, and cutting-edge biological techniques. He brings a diverse skill set cultivated through extensive experience in molecular medicine research together with skills in Python and R programming.
Magnus Molin, PhD.
CTO
Magnus has 17 years of experience from leading roles in diagnostics development including nucleic acid detection, microfluidics, microarray technologies and immunodiagnostics. Magnus has a Master of Science in biology and a PhD in medical virology from Uppsala University, and was a post-doctoral fellow at University of California, San Francisco (UCSF).